IP Library Granted Patent US 10,478,524
Granted Patent B2
US 10,478,524 · App. 15/600,351 · Granted Nov 19, 2019

Tissue-engineered silk organs

Inventors: David L. Kaplan (Concord, MA); Fiorenzo G. Omenetto (Lexington, MA); Jeffrey K. Marchant (Littleton, MA); Noorjahan Panjwani (Medford, MA); Brian Lawrence (Minneapolis, MN)
Assignee: TRUSTEES OF TUFTS COLLEGE
A61L27/3604A61L27/225A61L27/227A61L27/3804A61L27/3839A61L27/3891A61L27/56C12N5/0068C12N5/0621G01N33/5044A61L2300/412C12N2533/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,478,524
App. No.
15/600,351
Granted
Nov 19, 2019
Kind
B2
Abstract

This invention relates to a lamellae tissue layer, comprising a grooved silk fibroin substrate comprising tissue-specific cells. The silk fibroin substrates provides an excellent means of controlling and culturing cell and extracellular matrix development. A multitude of lamellae tissue layers can be used to create a tissue-engineered organ, such as a tissue-engineered cornea. The tissue-engineered organ is non-immunogenic and biocompatible.

Claims (14)

1. A grooved substrate comprising silk fibroin,

wherein thickness of the substrate ranges from 10 nm to 1 mm,

wherein groove width is at least 125 nm, and

wherein the substrate comprises micropores,

wherein spacing between the micropores is 50 μm to 100 μm and,

wherein an average diameter of the micropores ranges from 100 nm to 10 μm.

2. The grooved substrate of claim 1 , wherein groove thickness depth is at least 100 nm.

3. The grooved substrate of claim 1 , wherein the silk is selected from the group consisting of silkworm silk, spider silk, transgenic silk and genetically engineered silk.

4. The grooved substrate of claim 1 , wherein the substrate comprises patterned diffractive optical surfaces.

5. The grooved substrate of claim 1 , wherein the substrate comprises beta-sheet crystallinity, and

wherein the beta-sheet crystallinity is induced by water annealing.

6. The grooved substrate of claim 1 , wherein the micropores are created through the use of poly(ethylene oxide) phase separation chemistry, laser ablation techniques, or a combination thereof.

7. The grooved substrate of claim 1 , wherein the substrate is non-immunogenic, and biocompatible.

8. The grooved substrate of claim 1 , further comprising at least one non-patterned silk film or circular patterned silk film.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 22, 2018
From: TUFTS UNIVERSITY BOSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045664/0409 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: KAPLAN, DAVID L.; OMENETTO, FIORENZO; MARCHANT, JEFFREY K.; PANJWANI, NOORJAHAN; LAWRENCE, BRIAN
To: TRUSTEES OF TUFTS COLLEGE
Reel/Frame 042575/0322 →
Continuity (5)
Division 14793464 · Jul 7, 2015
Division 12528634
Provisional Application 60973023 · Sep 17, 2007
Provisional Application 60903800 · Feb 27, 2007
Related Publication 20180036453A1 · Feb 8, 2018